A groundbreaking vaccine to protect infants from severe respiratory syncytial virus (RSV) is now available in South Africa’s private healthcare sector. Still, a decision on its inclusion in the public programme remains pending. The country’s National Advisory Group on Immunisation (NAGI) has formally recommended the RSV infant vaccine for all pregnant women. They have left the final decision to the…
Tag: RSV
-
New COVID-19 Variant No Threat to South Africa
While the COVID-19 pandemic has subsided from its peak, the virus continues to circulate and evolve globally. The recent designation of a new variant, NB.1.8.1, by the World Health Organisation (WHO) has sparked online discussion. South Africa’s leading scientists are urging calm while highlighting a more pressing local issue: vaccine accessibility. The National Institute for Communicable Diseases (NICD) has confirmed…